Palonosetron HCl BP
Composition : Palonosetron INN 0.25mg IV Injection.
Indication : Moderately emetogenic cancer chemotherapy : prevention of acute and delayed nausea and vomiting associated with initial and repeat courses.
Dosage and administration : A single 0.25mg I.V dose administered over 30 seconds. Dosing should occur 30 minutes before the start of chemotherapy.
Use in pregnancy and lactation :Pregnancy : Pregnancy category B. There are no adequate and wellcontrolled studies in pregnant women. Therefore, Palonosetron should be used during pregnancy only if clearly needed.
Packing : Palnox 0.25 Injection (IV) : 1 x 3's Ampoules (5ml) in a blister pack.